WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Ownership - Who owns Roivant Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Roivant Sciences Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard PulikCFO2025-07-281,919$11.35
$21.78kSell
Eric VenkerPresident Immunovant CEO2025-07-21100,000$11.52
$1.15MSell
Eric VenkerPresident Immunovant CEO2025-07-21100,000$3.85
$385.00kBuy
James C. MomtazeeDirector2025-07-17241$11.65
$2.81kSell
Richard PulikCFO2025-06-281,653$11.39
$18.83kSell
Vivek Ramaswamy10% Owner2025-06-20577,007$11.46
$6.61MSell
Eric VenkerPresident COO2025-06-20100,000$11.45
$1.15MSell
Eric VenkerPresident COO2025-06-20100,000$3.85
$385.00kBuy
Richard PulikCFO2025-06-201,503$11.45
$17.21kSell
Vivek Ramaswamy10% Owner2025-06-18565,266$11.45
$6.47MSell

1 of 13

ROIV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ROIV insiders and whales buy or sell their stock.

ROIV Shareholders

What type of owners hold Roivant Sciences Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Qvt Financial LP17.50%119,488,624$1.40BInsider
Daniel Allen Gold16.48%112,544,780$1.32BInsider
Dexcel Pharma Technologies Ltd15.06%102,849,443$1.21BInsider
Keith S. Manchester11.33%77,373,448$909.14MInsider
Svf Investments Uk Ltd10.69%73,031,667$858.12MInsider
Sumitomo Chemical Co Ltd10.43%71,251,083$837.20MInsider
Vivek Ramaswamy7.42%50,641,965$595.04MInsider
Blackrock Inc5.90%40,316,307$473.72MInstitution
Vanguard Group Inc5.76%39,326,336$462.08MInstitution
Mayukh Sukhatme3.00%20,494,245$240.81MInsider

1 of 3

ROIV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ROIV19.71%80.29%Net SellingNet Selling
MDGL9.83%90.17%Net SellingNet Buying
HALO66.15%29.61%Net SellingNet Selling
TECH58.75%2.46%Net BuyingNet Buying
CORT24.71%75.29%Net BuyingNet Selling
View Top Biotech Stocks

Roivant Sciences Stock Ownership FAQ

Who owns Roivant Sciences?

Roivant Sciences (NASDAQ: ROIV) is owned by 24.74% institutional shareholders, 100.79% Roivant Sciences insiders, and 0.00% retail investors. Qvt Financial LP is the largest individual Roivant Sciences shareholder, owning 119.49M shares representing 17.50% of the company. Qvt Financial LP's Roivant Sciences shares are currently valued at $1.40B.

If you're new to stock investing, here's how to buy Roivant Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.